Traduction de «pouvoir pathogène » (Français → Anglais) :

Acute oral toxicity, pathogenicity and infectiveness

Acute inhalation toxicity, pathogenicity and infectiveness

The key point is that the Pacific Ocean louse is genetically different from the Atlantic Ocean louse, and that largely explains why we don't see the same pathology, the same disease, the same virulence and pathogenicity, if you will, and ability to cause disease as is seen in other countries. It's a different animal, a different parasite.

Action n° 10: Strengthen surveillance systems on AMR and antimicrobial consumption in animal medicine Inclusion of a legal basis for the monitoring of AMR in animal pathogens in its forthcoming proposal for a new Animal Health Law. Promotion and extension of the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) with the collaboration of EMA to obtain harmonised data on the usage per animal species and production categories as well as for different indications from all Member States. Review of the monitoring of AMR in zoonotic bacteria and/or indicators. With the support of the relevant EU agencies, establish harmonisa ...[+++]tion between human and veterinary surveillance to allow comparison of data.

The second component is what I was talking about earlier, which is the fish health audit and surveillance program, where we will coordinate our visits to go and actually collect dead fish of diagnostic quality and have those submitted and screened for pathogens of concern to Canada and internationally, not to mention the endemic infectious agents that are just in the ocean in B.C. The third component is to coordinate visits to actually go and conduct sea lice counts at the farm, shoulder to shoulder with the farmer.

These laboratories should be provided with the opportunity to continue to operate at a biosafety level 2 and be permitted to apply for pathogen-specific exemptions for those risk group 3 pathogens that they routinely or occasionally encounter, such as HIV. Alternatively, a notification process for risk group 3 pathogens could be implemented that would require the community laboratories operating at biosafety level 2 to notify the Public Health Agency of Canada when they encounter risk group 3 pathogens in the course of their work.